Brooklyn Investment Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
72,584
+11,856
+20% +$165K 0.03% 559
2025
Q4
$857K Buy
60,728
+42,283
+229% +$593K 0.04% 405
2025
Q3
$278K Sell
18,445
-809
-4% -$11.6K 0.04% 456
2025
Q2
$289K Buy
19,254
+12,861
+201% +$184K 0.04% 456
2025
Q1
$84.3K Buy
6,393
+5,313
+492% +$73.3K 0.02% 570
2024
Q4
$17.1K Buy
+1,080
New +$16.2K 0.01% 801

Other funds holding RDY

Brooklyn Investment Group's RDY Position: Q1 2026 in Review

Brooklyn Investment Group increased its Dr. Reddy's Laboratories (RDY) stake by 20% in Q1 2026, buying an estimated $165K and bringing the position to 72,584 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #559.

Brooklyn Investment Group first reported a position in RDY in Q4 2024 and has held it in 6 quarters since. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Brooklyn Investment Group held 72,584 shares of Dr. Reddy's Laboratories worth $1.01M as of Q1 2026.
  • Brooklyn Investment Group bought 11,856 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $165K.
  • Dr. Reddy's Laboratories made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #559 holding.
  • Brooklyn Investment Group first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 6 quarters since.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.